Facebook
Twitter
- ACTION ALERT: Help Us Stop the #RxRacket! (April 10, 2013)
- Resources to Find Affordable, High Value Medications (April 08, 2013)
- Conflicts of Interest Resources and Tools (April 10, 2013)
- New York Times Editorial: Who Else is Paying Your Doctor? (January 20, 2012)
- Boston Globe: Drug Firm Payments to Doctors Declining (September 08, 2011)
- New York Times: Deal in Place for Inspecting Foreign Drugs (August 13, 2011)
- Reuters: New Drug Regulator Asks Congress for More Power (July 29, 2011)
- Chemical & Engineering News: Pharmaceuticals: Report Recommends Measures to Mitigate Risks in a Global Supply Chain (July 18, 2011)
- National Journal: Pew Study Finds Gaps in FDA Oversight of Imported Drugs (July 13, 2011)
- Wall Street Journal: Supreme Court: Pharma Companies Can Buy Prescription Data (June 23, 2011)
- PBS NewsHour: FDA Lays Out Global Strategy to Monitor for Dangerous Foods, Drugs (June 22, 2011)
- San Francisco Chronicle: FDA Plan Aims to Increase Import Safety (June 20, 2011)
- Chicago Tribune: Baxter Loses First Heparin Case (June 09, 2011)
- Vermont Digger: Vermont Data Mining Bill In Doubt with U.S. Supreme Court (May 18, 2011)
- Fortune Magazine: Drug Theft Goes Big (March 31, 2011)
- CNN Money: FDA Says Another Tainted Drug Crisis Seems Inevitable (March 14, 2011)
- 60 Minutes: The Fight Against Counterfeit Drugs (March 13, 2011)
- Wall Street Journal: House Investigates Heparin Crisis (February 23, 2011)
- Bloomberg: More Outsourcing Planned for Overseas FDA Inspections (February 10, 2011)
- NPR: Glaxo Exec Concedes Drug Industry 'Lost Its Way' And Prescribes Changes (January 24, 2011)
- New York Times: Will Johnson & Johnson Get Its Act Together? (January 15, 2011)
- 60 Minutes: Bad Medicine: The Glaxo Case (January 02, 2011)
- Harkin, Bennet Applaud Dingell Drug Safety Bill (December 17, 2010)
- New York Times: FDA Says Johnson & Johnson Unit Falls Short of Standards (November 26, 2010)
- MSNBC: Top-Name Drug Recalls a Bitter Pill for Consumers (November 10, 2010)
- Boston Globe Editorial: FDA Relies Too Much on Tipoffs, Not Enough on Drug Checks (November 09, 2010)
- New York Times: GlaxoSmithKline Pays $750 Million Over Tainted Drugs (October 26, 2010)
- Reuters: Musty Odor Sparks Another Tylenol Recall (October 19, 2010)
- ProPublica: Consumer Reports: Most Patients Worry About Pharma Payments to Doctors (October 18, 2010)
- Wall Street Journal: FDA Finds Heparin Maker Violations (October 14, 2010)
- Reuters: Pfizer Says Recalled 191,000 Lipitor Bottles (October 07, 2010)
- Pharmalot: Congress to Hold Another Johnson & Johnson Recall Hearing (September 16, 2010)
- New York Times: The Public's Quiet Savior From Harmful Medicines (September 13, 2010)
- New York Times: Medical Industry Ties Often Undisclosed in Journals (September 13, 2010)
- PBS NewsHour: FDA's Safety Role in Question After Drug Recall (September 01, 2010)
- Denver Post Op-Ed: The Drug Safety and Accountability Act is Overdue (August 14, 2010)
- The Hill Healthwatch blog: Senate bill would bolster drug safety requirements (August 03, 2010) Director of Prescription Access and Quality Marcia Hams quoted on the effect outsourcing has on the production and quality of prescription drugs. The article addresses the Drug Safety and Accountability Act of 2010 Sen. Bennet (D-CO) introduced.
- USA Today: Voters trust drugs made in USA, but few are (August 03, 2010) According to a survey by the Pew Prescription Project fewer than one in 10 people feel confident in drugs manufactured in India or China. However, many consumers don't realize that more than 80% of the products used to make or package drugs sold in the U.S. are made in other countries.
- WSJ Health Blog: Follow-Up: Massachusetts Gift Ban Won't Be Repealed (August 02, 2010)
- Metrowest Daily News: Massachusetts advocate says new health law brings transparency (April 26, 2010)
- "Marketplace" follows academic detailers in Pennsylvania (February 24, 2010)
- Minnesota Star Tribune: Lawmakers hear Rx gifts, academic detailing, and data-mining bills (January 25, 2010)
- Radio Boston: Using academic detailing to combat drug reps' sales pitches to doctors (January 13, 2010)
- Boston Globe: Medical schools, NIH should ban all ghostwriting (August 25, 2009)
- Associated Press: Community Catalyst's Marcia Hams expects continued momentum on Rx data-mining (December 11, 2009)
